Polsinelli Adds Laura Angelini as Health Care Litigation in Boston

Polsinelli has added trial lawyer Laura B. Angelini as a shareholder in its health care litigation practice in Boston, the firm announced.

Angelini joins the firm’s Boston office with experience defending health care organizations and executives in government investigations and enforcement matters nationwide. Her addition follows the recent hiring of Benjamin Wallfisch in Denver as part of the firm’s expansion of its health care litigation bench.

Angelini represents clients in civil, criminal, and administrative actions involving the False Claims Act, Anti-Kickback Statute, Stark Law, and HIPAA. Her cases often involve alleged Medicare and Medicaid billing violations, off-label promotion, drug diversion, and patient privacy breaches.

She advises pharmaceutical and medical device manufacturers and distributors, hospitals, academic medical centers, behavioral health organizations, physician practice groups, and licensed professionals.

“Polsinelli has long been a leader in health care, and Laura’s arrival further expands that position,” said Chase Simmons, chairman and CEO of Polsinelli.

Sherri T. Alexander, chair of the firm’s health care litigation practice, said Angelini’s trial experience and background in government investigations will strengthen the firm’s ability to guide clients through regulatory scrutiny and complex litigation.

Angelini said the firm’s national health care litigation platform and collaborative approach influenced her decision to join. She said she plans to expand the firm’s white-collar presence in Boston.

Angelini earned her law degree from Boston College Law School and her undergraduate degree, magna cum laude, from Boston College.

Polsinelli’s health care litigation team represents clients in disputes and government investigations in litigation, arbitration, and administrative proceedings. The firm said the group includes former Department of Justice attorneys, former state Medicaid fraud unit attorneys, and former in-house counsel to private and publicly traded health care companies.